Literature DB >> 19287833

Incidence and clinical characteristics of the infection by the respiratory syncytial virus in children admitted in Santa Casa de São Paulo Hospital.

Rogério Pecchini1, Eitan N Berezin, Maria C Calahani Felício, Saulo D Passos, Maria Cândido O de Souza, Lourdes Rehder de Andrade Vaz de Lima, Mirthes Ueda, Tokiko Kyomen Matsumoto, Edison L Durigon.   

Abstract

The purpose of this study was to identify the rate of infections due to RSV and other viruses in children. In addition we have analyzed demographic data and clinical characteristics of the RSV-positive patients comparing with patients infected by other respiratory viruses. We also described the seasonality of the RSV occurrence in a hospital in São Paulo. Children below 5 years old admitted in Santa Casa de São Paulo Hospital between February 2005 and September 2006 due to acute respiratory infections (ARI) were included. A nasopharyngeal specimens were obtained with sterile No. 5 French feeding catheters as soon as possible (usually within 24 h). Specimens were kept refrigerated at 4 degrees C and transported to Adolfo Lutz Institute, where the indirect immunofluorescent assay was performed. Virus identified by these assay included RSV, Adenovirus, Influenza A and B virus and Parainfluenza 1, 2, and 3. Clinical data from each group was compared. Four hundred and fifty five cases were included in the study, with 30% positive for some type of virus. Viruses that were identified included Respiratory Syncytial Virus (73.03%), Influenza (8.42%), Parainfluenza (8.42%) and Adenovirus (3.37%). We divided the subjects in 3 groups: Group 1 RSV-Positive, Group 2 Other Positive Viruses and Group 3 Negative for Respiratory Virus. Mean age (months) was of 7.5 for RSV-positive children, 7.6 for other viruses, and 8 for negative for respiratory virus. The RSV-Positive Group was significantly younger than the Group Negative for Respiratory Virus (p<0.05). Signs of UAI were more present in the Positive RSV Group (p<0.05). General mortality was of 2.41%. There was a higher incidence of RSV between the months of March and August in the two years of the study. Our study indicates RSV as the most prevalent viral agent in children admitted due to (ARI), especially in infants below 3 months old. We have also found that infections due to RSV can occur in months others than the classic seasonal period.

Entities:  

Mesh:

Year:  2008        PMID: 19287833     DOI: 10.1590/s1413-86702008000600006

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  16 in total

1.  Respiratory infections in children up to two years of age on prophylaxis with palivizumab.

Authors:  Ana Isabel M P Monteiro; Nancy Cristina J Bellei; Alessandra Ramos Sousa; Amélia Miyashiro N dos Santos; Lily Yin Weckx
Journal:  Rev Paul Pediatr       Date:  2014-06

2.  Shift in the timing of respiratory syncytial virus circulation in a subtropical megalopolis: implications for immunoprophylaxis.

Authors:  Terezinha M Paiva; Maria A Ishida; Margarete A Benega; Clóvis R A Constantino; Daniela B B Silva; Kátia C O Santos; Maria I Oliveira; Helena A Barbosa; Telma R M P Carvalhanas; Cynthia Schuck-Paim; Wladimir J Alonso
Journal:  J Med Virol       Date:  2012-11       Impact factor: 2.327

3.  A survey strategy for human respiratory syncytial virus detection among haematopoietic stem cell transplant patients: epidemiological and methodological analysis.

Authors:  Luciana Peniche Moreira; Aripuanã Sakurada Aranha Watanabe; Emerson Carraro; Ellen Ricci Monteiro da Silva; Sandra Baltazar Guatura; Celso Granato; Nancy Junqueira Bellei
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-02       Impact factor: 2.743

Review 4.  Clinical presentation and microbiological diagnosis in paediatric respiratory tract infection: a systematic review.

Authors:  Hannah V Thornton; Peter S Blair; Andrew M Lovering; Peter Muir; Alastair D Hay
Journal:  Br J Gen Pract       Date:  2015-02       Impact factor: 5.386

5.  Prevalence and clinical features of respiratory syncytial virus in children hospitalized for community-acquired pneumonia in northern Brazil.

Authors:  Letícia Martins Lamarão; Francisco Luzio Ramos; Wyller Alencar Mello; Mirleide Cordeiro Santos; Luana Soares Barbagelata; Maria Cleonice Aguiar Justino; Alexandre Ferreira da Silva; Ana Judith Pires Garcia Quaresma; Veronilce Borges da Silva; Rommel Rodríguez Burbano; Alexandre Costa Linhares
Journal:  BMC Infect Dis       Date:  2012-05-16       Impact factor: 3.090

6.  Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review.

Authors:  Kimberly Bloom-Feshbach; Wladimir J Alonso; Vivek Charu; James Tamerius; Lone Simonsen; Mark A Miller; Cécile Viboud
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

7.  Acute lower respiratory tract infection due to respiratory syncytial virus in a group of Egyptian children under 5 years of age.

Authors:  Aya M Fattouh; Yasmeen A Mansi; Mervat G El-Anany; Amany A El-Kholy; Hanaa M El-Karaksy
Journal:  Ital J Pediatr       Date:  2011-04-06       Impact factor: 2.638

Review 8.  Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis.

Authors:  Renato T Stein; Louis J Bont; Heather Zar; Fernando P Polack; Caroline Park; Ami Claxton; Gerald Borok; Yekaterina Butylkova; Colleen Wegzyn
Journal:  Pediatr Pulmonol       Date:  2016-10-14

9.  First introduction of pandemic influenza A/H1N1 and detection of respiratory viruses in pediatric patients in Central African Republic.

Authors:  Emmanuel Nakouné; Vianney Tricou; Alexandre Manirakiza; Francis Komoyo; Benjamin Selekon; Jean Chrysostome Gody; Kathleen Victoir; Philippe Buchy; Mirdad Kazanji
Journal:  Virol J       Date:  2013-02-08       Impact factor: 4.099

10.  Respiratory syncytial virus epidemic periods in an equatorial city of Brazil.

Authors:  Fernanda E A Moura; Anne C B Perdigão; Joyce F Ribeiro; Caroline M G D Florêncio; Francisco M S Oliveira; Samuel A R Pereira; Viviane F Botosso; Marilda M Siqueira; Luciano M Thomazelli; Raquel N Caldeira; Danielle B L Oliveira; Edison L Durigon
Journal:  Influenza Other Respir Viruses       Date:  2013-03-20       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.